Item | Total correlation coefficient | Factor | |
---|---|---|---|
1 | 2 | ||
Experiences related to ADRs (0.62)a | |||
 Experience of concerns about the occurrence of ADRs | 0.45 | 0.73 |  |
 Experience of seeking drug safety information | 0.51 | 0.77 |  |
 Experience of reading insert paper thoroughly | 0.27 | 0.50 |  |
 Experience with ADRs | 0.37 | 0.63 |  |
 Experience of requests HCPs for counselling in drug safety | 0.28 | 0.50 |  |
 Eigenvalue |  | 2.02 |  |
 Cumulative variance explained (%) |  | 40.49 |  |
Knowledge of ADRs (0.70)a | |||
 All medications can cause adverse effects | 0.47 | 0.68 |  |
 Adverse effects can occur even if a medication is administered correctly | 0.40 | 0.61 |  |
 Adverse effects can occur when a medication is double-dosed | 0.34 | 0.54 |  |
 Adverse effects can occur when a medication is taken more frequently | 0.57 | 0.79 |  |
 Adverse effects can occur when medications are stopped abruptly | 0.51 | 0.74 |  |
 Eigenvalue |  | 2.29 |  |
 Cumulative variance explained (%) |  | 45.84 |  |
Attitude on motives of SR (0.72)a | |||
 Necessity of reporting ADRs | 0.37 | 0.19 | 0.78b |
 Duty to report ADRs | 0.31 | 0.08 | 0.83b |
 Expectation of preventing similar ADRs from occurring in others | 0.57 | 0.84b | 0.13 |
 Expectation of improving drug safety | 0.54 | 0.81b | 0.12 |
 Expectation of improving healthcare service | 0.62 | 0.86b | 0.16 |
 Eigenvalue |  | 2.42 | 1.07 |
 Cumulative variance explained (%) |  | 48.40 | 69.84 |
Attitude on barriers against SR (0.76)a | |||
 Cannot recognise ADRs | 0.43 | 0.21 | 0.66b |
 No serious ADRs | 0.45 | 0.09 | 0.83b |
 ADRs resolved | 0.43 | 0.10 | 0.78b |
 No personal benefit | 0.53 | 0.68b | 0.26 |
 No real improvement in system | 0.55 | 0.71b | 0.26 |
 Not my job | 0.45 | 0.73b | 0.06 |
 Counsel with HCPs instead of SR | 0.52 | 0.56b | 0.37 |
 Breach of privacy | 0.34 | 0.67b | −0.05 |
 Eigenvalue |  | 3.05 | 1.29 |
 Cumulative variance explained (%) |  | 38.07 | 54.16 |